Make no Mistake I am an NTEK long and Big Supporter
I
Make no Mistake I am an NTEK long and Big Supporter
I have been for a long time! But I just hope everyone realizes the value of getting to the market first! So this delay could be delaying our up-list by a huge amount of time!
EVERYONE PLEASE NOTE IT is Percentage of the company and value you want, not amount of shares!
If Ntek makes a deal (and we know that they do like to use their shares instead of incurring debt)
They are going to have to pay the other company with "cheapies" Meaning that the cheapness of the shares, while you may be adding more, means that deals will take more "Remember the 40 mllion in Escrow"
IF THEY DO THE SAME DEAL TODAY AND SHARES ARE AT .06 instead of .12 (the company would need 80 million for the same amount)
So lets get this company trading at a reasonable price, so we can reduce shares and up-list sooner. In a penny stock you always want less shares with more value
Everyone: please give me 1 million shares at .24 instead of 4 million at .06
we will get bigger dividends on less shares, volatility will not be as bad, and the company will gain more respect. Plus buybacks will be big, because they will reduce the shares, and end this Pinksheet stuff.
Nanotech Entertainment Inc. (NTEK) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Understanding Oscar Health's Recent Options Activity In the fast-paced world of trading, Oscar Health Inc’s (NYSE: OSCR) recent options activity has captured significant attention among savvy investors. Notably, there has been a notable bullish sentiment from wealthy investors towards this health insurance company. Tracking public options data reveals movements that...
Continue Reading
Better Choice Company Settles on Halo Asia Sale Better Choice Company, Inc. (BTTR), a leader in pet health and wellness, has recently reached a significant milestone by signing a definitive agreement to sell its Halo business in Asia. This sale is projected to generate total gross proceeds of $8.1 million, which encompasses $6.5 million in cash at the closing of the deal....
Continue Reading
Fastenal Prepares for Earnings Report Fastenal (NASDAQ: FAST) is gearing up to release its quarterly earnings report. Investors are keenly anticipating the upcoming announcement, as it offers a glimpse into the company's financial performance. This article provides essential insights and analysis for those eager to understand what to expect from Fastenal's announcement....
Continue Reading
Compass Therapeutics Advances Cancer Research BOSTON — Compass Therapeutics, Inc. (Nasdaq: CMPX), a promising player in the biotechnology sphere focused on developing innovative therapies for cancer, has made significant strides in its clinical research. The company has announced that the first patient has been dosed in a groundbreaking Investigator Sponsored Trial...
Continue Reading
Overview of the ECB Fine Imposed on LHV Group The European Central Bank (ECB) has recently informed AS LHV Group about a decision to levy an administrative fine amounting to EUR 405 thousand. This fine is linked to an error identified in the consolidated regulatory reporting for a specified timeframe. The issue arose from discrepancies in how the equity of LHV Bank...
Continue Reading